SARAH DE BELEN: Open Payments
NPI 1720573017 · DUARTE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$168 in 7 payments from 5 companies in 2025. Trend: 2023 $220 · 2024 $274 · 2025 $168
Food & beverage: $168
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $49 |
| Astellas Pharma US Inc | 2 | $46 |
| Melinta Therapeutics, LLC | 1 | $32 |
| Janssen Biotech, Inc. | 1 | $27 |
| Genentech USA, Inc. | 1 | $15 |
Products named: EPKINLY, Vyloy, Rezzayo, DARZALEX, Venclexta.
Industry payments across CA — which companies pay providers there.
